Your browser doesn't support javascript.
loading
Potential Significant Changes in Nuclear Regulatory Commission Policies Regarding Training and Experience Requirements for the Use of Radiopharmaceuticals.
Wallner, Paul E; Lieto, Ralph P; Dillehay, Gary L; Ghesani, Munhir V; Rosenthal, Seth A; Rosenzweig, Kenneth E; Steinberg, Michael L; Yoo, Don C; Small, William.
Afiliação
  • Wallner PE; 21st Century Oncology, Moorestown, New Jersey; Chair, Work Group of the ACR Commission on Government Relations, Federal Regulatory Committee; Chair, Physicians Consortium for Performance Improvement, Oncology Technical Expert Panel. Electronic address: paul.wallner@21co.com.
  • Lieto RP; Monroe, Michigan.
  • Dillehay GL; Feinberg School of Medicine, Chicago, Illinois.
  • Ghesani MV; Chief of Nuclear Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Rosenthal SA; Sutter Medical Group, Sacramento, California.
  • Rosenzweig KE; Icahn School of Medicine at Mount Sinai, New York, New York; Chair, Department of Radiation Oncology, Mount Sinai Health System, New York, New York; Vice Chair, ACGME Radiation Oncology Review Committee.
  • Steinberg ML; David Geffen School of Medicine at UCLA, Los Angeles, California; Chair, Radiation Oncology, University of California, San Francisco, San Francisco, California.
  • Yoo DC; The Warren Alpert Medical School of Brown University, Providence, Rhode Island; Chair, ACR Commission on Nuclear Medicine and Molecular Imaging.
  • Small W; Chair, Department of Radiation Oncology, and Director, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; Co-Chair, NRG Oncology Gynecologic Cancer Committee; Chair, ACR Commission on Radiation Oncology.
J Am Coll Radiol ; 18(2): 312-317, 2021 Feb.
Article em En | MEDLINE | ID: mdl-32860755

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Radiofarmacêuticos / Medicina Nuclear Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Radiofarmacêuticos / Medicina Nuclear Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article